Comparison

Teneliximab European Partner

Item no. HY-P99321-1mg
Manufacturer MedChem Express
CASRN 299423-37-3
Amount 1 mg
Category
Type Inhibitor
Specific against other
Purity 99.0
Dry ice Yes
Citations [1]Maria A Argiriadi, et al. CD40/anti-CD40 antibody complexes which illustrate agonist and antagonist structural switches. BMC Mol Cell Biol. 2019 Aug 5;20(1):29.<br>[2]Andrew B Adams, et al. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J Immunol. 2005 Jan 1;174(1):542-50.
Smiles [Teneliximab]
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias BMS 224819; Chi220; Anti-Human CD40 Recombinant Antibody
Available
Product Description
Teneliximab (BMS-224819) is a chimeric monoclonal antibody, blocks the CD40-CD40L interaction. Teneliximab (BMS-224819) has partial agonist activity resulting in some signaling through CD40 and peripheral B cell depletion[1].
StorageTemperature
Store at -80°C for 2 years
Shipping
Dry Ice
Manufacturers Applications
COVID-19-anti-virus
MolecularWeight
N/A
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer; Inflammation/Immunology
Solubility
10 mM in H2O
Pathway
Apoptosis
Manufacturers Product type
Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close